Your search returned 3 results.

Results
	1.	The Selective Oral Immunomodulator Vidofludimus in Patients with Active Rheumatoid Arthritis: Safety Results from the COMPONENT Study. [electronic resource] by Muehler, Andreas Kohlhof, Hella Groeppel, Manfred Vitt, Daniel Producer: 20200421 In: Drugs in R&D vol. 19 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Safety, Tolerability and Pharmacokinetics of Vidofludimus calcium (IMU-838) After Single and Multiple Ascending Oral Doses in Healthy Male Subjects. [electronic resource] by Muehler, Andreas Kohlhof, Hella Groeppel, Manfred Vitt, Daniel Producer: 20210702 In: European journal of drug metabolism and pharmacokinetics vol. 45 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	4SC-101, a novel immunosuppressive drug, inhibits IL-17 and attenuates colitis in two murine models of inflammatory bowel disease. [electronic resource] by Fitzpatrick, Leo R Deml, Ludwig Hofmann, Claudia Small, Jeffrey S Groeppel, Manfred Hamm, Svetlana Lemstra, Sylvia Leban, Johann Ammendola, Aldo Producer: 20110128 In: Inflammatory bowel diseases vol. 16 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

Refine your search